Mistral AI's fundraising success, while impressive, doesn't automatically mean the AI Act is viable or that it provides definitive context for the Solsice debate; we need a clear chain of custody for that analytical leap. The ownership of how that fundraising data links to broader regulatory viability would need proper documentation outlining the cause-and-effect. Without a process for connecting a single company's financial win to the overall regulatory framework, it's just one data point, like a patient with an uncommon symptom being used to justify a change to general guidelines.